GROSSPATTERN / DETERMINISTIC INSIGHT

Cash generation inflected

Adaptive Biotechnologies Corp · Cash Conversion Inflection · effective Jun 30, 2026

EVIDENCE CONFIDENCE88%1 independent group · 58 governed parents

LIFECYCLEWEAKENED

HISTORICAL40th pct

PEER DIVERGENCE—

PERSISTENCE4 periods

CURRENTNESSCURRENT/MATCH

VALUE GATESURFACE ELIGIBLE

Why this matched

Inspectable conditions

Each condition comes from governed filing metrics. Context does not assert causality or predict price.

Dimension	Recent direction	Multi-period	Magnitude	Historical percentile
Cash Generation	IMPROVING	IMPROVING	12.1667	40.000

Method and lineage

DEFINITION[email protected][email protected]

EVIDENCE1 independent / 58 parentsRights, quality, lineage, currentness, and publication gates passed.

PROFILEGeneral CorporateProfile-specific interpretation.